 |
|
Intravitreal Bevacizumab for Treatment of Refractory Central Serous Choroidoretinopathy
Morteza Entezari, Alireza Ramezani, Mehdi Yaseri
Korean J Ophthalmol. 2012;26(2):139-142. Published online 2012 Mar 22 DOI: https://doi.org/10.3341/kjo.2012.26.2.139
|
|
Citations to this article as recorded by
 Central serous chorioretinopathy: An evidence-based treatment guideline
Helena M.A. Feenstra, Elon H.C. van Dijk, Chui Ming Gemmy Cheung, Kyoko Ohno-Matsui, Timothy Y.Y. Lai, Hideki Koizumi, Michael Larsen, Giuseppe Querques, Susan M. Downes, Suzanne Yzer, Mark P. Breazzano, Yousif Subhi, Ramin Tadayoni, Siegfried G. Prigling
Progress in Retinal and Eye Research.2024; : 101236. CrossRef Intravitreal anti-vascular endothelial growth factor for the treatment of chronic central serous retinopathy: a meta-analysis of the literature
Mathew Palakkamanil, Monique Munro, Abhishek Sethi, Feisal Adatia
BMJ Open Ophthalmology.2023; 8(1): e001310. CrossRef Changes in Aqueous Concentrations of Various Cytokines after Intravitreal Bevacizumab Injection for Chronic Central Serous Chorioretinopathy
Jooye Park, Sung Ha Hwang, Dong Heun Nam, Dae Yeong Lee
Korean Journal of Ophthalmology.2023; 37(6): 453. CrossRef Central serous chorioretinopathy: Towards an evidence-based treatment guideline
Thomas J. van Rijssen, Elon H.C. van Dijk, Suzanne Yzer, Kyoko Ohno-Matsui, Jan E.E. Keunen, Reinier O. Schlingemann, Sobha Sivaprasad, Giuseppe Querques, Susan M. Downes, Sascha Fauser, Carel B. Hoyng, Felice Cardillo Piccolino, Jay K. Chhablani, Timothy
Progress in Retinal and Eye Research.2019; 73: 100770. CrossRef Intravitreal bevacizumab administration for the treatment of chronic central serous chorioretinopathy
Aliagha Alishiri, Khosrow Jadidi, Seyed Aliasghar Mosavi, Hamidreza Torabi
Journal of Current Ophthalmology.2019; 31(4): 406. CrossRef Pharmacotherapy of Central Serous Chorioretinopathy: A Review of the Current Treatments
Pierluigi Iacono, Lisa Toto, Eliana Costanzo, Monica Varano, Maria Cristina Parravano
Current Pharmaceutical Design.2019; 24(41): 4864. CrossRef Clinical efficacy of anti-VEGF medications for central serous chorioretinopathy: a meta-analysis
Shangli Ji, Yemei Wei, Jiansu Chen, Shibo Tang
International Journal of Clinical Pharmacy.2017; 39(3): 514. CrossRef Success of Ranibizumab in Central Serous Chorioretinopathy Resistant to Bevacizumab
Ahmet Altun, Sevda Aydin Kurna, Osman Okan Olcaysu, Tomris Sengor, Suat Fazil Aki, Tugba Gencaga Atakan
Journal of Ocular Pharmacology and Therapeutics.2014; 30(10): 842. CrossRef Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review
Y-R Chung, E J Seo, H M Lew, K H Lee
Eye.2013; 27(12): 1339. CrossRef
|